Tag: Cancer
-
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Oct. 5, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. As…
-
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cycl…
-
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control.PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNewswire…
-
HCG Cancer Hospital Mumbai Treats 125+ Prostate Cancer Patients Without Surgery or Hospital Stay
Advanced SBRT offers precise prostate cancer treatment in just five sessions, powered by Versa HD and CyberKnife Mumbai’s first and only platformMUMBAI, India, Sept. 22, 2026 /PRNewswire/ — Prostate cancer treatment does not always require surgery or prolonged hospitalisation. At HCG Cancer Hospita…
-
There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource
New guideline for patients and caregivers explains the importance of assessments to tailor cancer care to every person, regardless of age. PLYMOUTH MEETING, Pa., Sept. 17, 2026 /PRNewswire/ — Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is publishi…
-
Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping
KYOTO, Japan, Sept. 16, 2026 /PRNewswire/ — Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal patients evaluating the safety and feasibility of a new nanoparticle-based platform to assist clinic…
Latest News
About the Author
Publicize Your Brand
Through our news networks, we raise millions of users’ awareness. We are among the world’s most reputable news networks.
